doi: 10.23937/2378-3656/1410150 Summary Keywords euglycemic diabetic ketoacidosis (euDKA), SGLT-2 inhibitor, GLP-1 receptor agonist, type 2 diabetes mellitus, adverse drug reaction Citation Gandecka-Pempera A, Naskrt D, Adamska A and Zozuliska-Zikiewicz D (2025) Severe euglycemic ketoacidosis following combined therapy with GLP-1 receptor agonist and SGLT-2 inhibitor, refractory to standard treatment: a case report
Understanding this timeline helps set realistic expectations and determine whether observed changes represent expected gradual decline or concerning rapid reversal suggesting dependency or underlying issues
Given that adequate hydration is always important, especially when any compound is affecting gastrointestinal function, this is something to consider
m6A modification precisely controls gene expression by influencing mRNA stability, translation efficiency, and cellular localization [9,10,11]
Jitendra Mehta Plastic Surgeon 47 years experience overall 1000 Consultation fee at clinic Dr